Kodiak Sciences, Inc. (KOD)
36.71
+0.59
(+1.63%)
USD |
NASDAQ |
May 29, 16:00
36.63
-0.08
(-0.22%)
After-Hours: 20:00
Kodiak Sciences EPS Diluted (Quarterly) : -0.9402 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | -0.317 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| ADMA Biologics, Inc. | 0.1889 |
| Revolution Medicines, Inc. | -2.291 |
| Dianthus Therapeutics, Inc. | -0.8501 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -58.16M |
| Total Expenses (Quarterly) | 58.16M |
| Enterprise Value | 2.284B |
| Earnings Yield | -11.37% |
| Normalized Earnings Yield | -11.37 |